Which GLP-1s does BCBS Illinois cover? 5 checked
BCBS Illinois publishes a policy on 5 GLP-1s we track. Of those, 3 are covered with prior approval and 2 depend on your plan. Each answer below names the conditions it covers and cites the document it came from.
Does BCBS Illinois cover Wegovy?
On some plans, yes. Each employer picks whether BCBS Illinois covers Wegovy, so two people with the same card can get different answers.
BCBSIL and its pharmacy benefit manager, Prime Therapeutics, offer weight-loss and GLP-1 coverage as an optional benefit that each employer group chooses to add or leave out, so many plans exclude anti-obesity drugs entirely. Where an employer elected the benefit, Wegovy is covered with prior authorization, generally at a BMI of 30 or higher (or 27 or higher with a weight-related condition) plus documented diet and lifestyle efforts. Members should confirm with their plan or employer whether weight-loss drugs are included before assuming coverage.
Source: Pharmacy Benefit for GLP-1 and/or Anti-Obesity Drug Therapy. Read August 28, 2026.
The full BCBS Illinois policy on Wegovy has the BMI bar, the step-therapy rule and what happens at renewal.
Does BCBS Illinois cover Zepbound?
On some plans, yes. Each employer picks whether BCBS Illinois covers Zepbound, so two people with the same card can get different answers.
BCBSIL runs its drug benefit through Prime Therapeutics, and weight-management drug coverage varies by the group's benefit selection, with many groups excluding anti-obesity drugs. Where the benefit is included, Zepbound needs prior authorization at a BMI of 30 or higher (or 27 or higher with a weight-related condition) plus at least 6 months of a reduced-calorie diet, physical activity, and behavioral changes. Zepbound is also covered for moderate-to-severe obstructive sleep apnea in adults with obesity, which is reviewed as a separate medical indication.
Source: Weight Management Prior Authorization with Quantity Limit Program Summary (Prime Therapeutics, effective 07-01-2026), policy Choice_Commercial_PS_Weight_Management_PAQL_ProgSum_07-01-2026_v4. Read August 28, 2026.
The full BCBS Illinois policy on Zepbound has the BMI bar, the step-therapy rule and what happens at renewal.
Does BCBS Illinois cover Mounjaro?
Yes, with prior approval. BCBS Illinois pays for Mounjaro once your prescriber gets the plan to sign off.
Blue Cross and Blue Shield of Illinois covers Mounjaro (tirzepatide) for type 2 diabetes on its 2026 commercial drug list, with prior authorization and quantity limits. The prior authorization criteria require that the patient has already tried an antidiabetic agent, so a first-line drug like metformin usually comes first. BCBSIL will not cover Mounjaro for weight loss. Tirzepatide for weight management is sold as Zepbound, which BCBSIL lists separately and covers only when the employer group elects an anti-obesity benefit.
Source: BCBSIL Prior Authorization/Step Therapy Program, GLP-1 Agonists, July 2026, policy 23466.0726. Read August 27, 2026.
The full BCBS Illinois policy on Mounjaro has the BMI bar, the step-therapy rule and what happens at renewal.
Does BCBS Illinois cover Ozempic?
Yes, with prior approval. BCBS Illinois pays for Ozempic once your prescriber gets the plan to sign off.
Blue Cross and Blue Shield of Illinois covers Ozempic for type 2 diabetes on its 2026 commercial drug lists, where it sits as a preferred brand and requires prior authorization plus a quantity limit of one pen every 28 days. Approval requires a documented diagnosis of type 2 diabetes and runs for 12 months before it has to be renewed. BCBSIL does not cover Ozempic for weight loss, because Ozempic is FDA-approved only for type 2 diabetes. The weight-loss semaglutide is Wegovy, a separate higher-dose product with its own coverage rules.
Source: BCBSIL 2656-Y IL Balanced Drug List, July 2026 (HCSC, Prime Therapeutics). Ozempic listed as preferred brand (P) with PA and QL of 1 pen per 28 days.. Read August 27, 2026.
The full BCBS Illinois policy on Ozempic has the BMI bar, the step-therapy rule and what happens at renewal.
Does BCBS Illinois cover Rybelsus?
Yes, with prior approval. BCBS Illinois pays for Rybelsus once your prescriber gets the plan to sign off.
Blue Cross and Blue Shield of Illinois covers Rybelsus for type 2 diabetes, with prior authorization required through its pharmacy benefit manager, Prime Therapeutics. Approval needs a documented type 2 diabetes diagnosis and a prior trial of another antidiabetic agent, and quantity limits apply. Rybelsus is not covered for weight loss, because it is FDA-approved for type 2 diabetes only. The weight-loss semaglutide is Wegovy, which BCBS Illinois lists separately with its own prior authorization.
Source: BCBSIL Prior Authorization/Step Therapy Program, GLP-1 (glucagon-like peptide-1) Agonists clinical criteria 23466.0726, policy 23466.0726. Read August 28, 2026.
The full BCBS Illinois policy on Rybelsus has the BMI bar, the step-therapy rule and what happens at renewal.
Every insurer we have read
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.